(NASDAQ: NPCE) Neuropace's forecast annual revenue growth rate of 15.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.26%.
Neuropace's revenue in 2025 is $84,306,000.On average, 3 Wall Street analysts forecast NPCE's revenue for 2025 to be $3,127,763,832, with the lowest NPCE revenue forecast at $3,116,513,945, and the highest NPCE revenue forecast at $3,138,816,929. On average, 3 Wall Street analysts forecast NPCE's revenue for 2026 to be $3,436,627,354, with the lowest NPCE revenue forecast at $3,214,253,490, and the highest NPCE revenue forecast at $3,825,289,638.
In 2027, NPCE is forecast to generate $4,445,345,375 in revenue, with the lowest revenue forecast at $4,310,051,542 and the highest revenue forecast at $4,580,639,208.